Pharmacogenetics: an opportunity for codevelopment of pharmaceuticals and diagnostics

Correlates of group sex participation among cisgender men who have sex with men in Seattle, WA.

Sexually transmitted diseases·2026

Community-engaged research in HIV implementation science: a cross-sectional assessment of meaningful engagement among community and academic recipients of 2021 and 2022 'ending the HIV epidemic' supplement awards.

Implementation science communications·2026

Challenges and Facilitators for HIV Testing Services and HIV Self-Testing Programming During Emergency Care in Kenya: A Qualitative Study of Patients.

Journal of sexual health and AIDS research·2026

Changes in sexual behaviors, network attributes, and STI testing among 15-44-year-olds by marital/cohabiting status and partner number: National Survey of Family Growth, 2008-19.

PloS one·2026

Community-engaged research in HIV implementation science: A cross-sectional assessment of meaningful engagement among community and academic recipients of 2021 and 2022 'ending the HIV epidemic' supplement awards.

Research square·2026

Improving HIV assisted partner services outcomes by eliciting additional partners after the initial encounter.

PLOS global public health·2026

The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.

Expert review of molecular diagnostics·2026

Theranostic innovation in infectious lung diseases: integrating biotechnology and nanotechnology for precision medicine.

Expert review of molecular diagnostics·2026

The expanding role of artificial intelligence in medical diagnosis: from molecular diagnostics and multi-omics to digital health and medical imaging.

Expert review of molecular diagnostics·2026

Protein signatures for the early detection of endometrial cancer in cervico-vaginal fluid.

Expert review of molecular diagnostics·2026

The association between normalized creatinine-to-cystatin C ratio and incident circadian syndrome in middle-aged and older adults: a national cohort study.

Expert review of molecular diagnostics·2026

What's in a name: the potential impact of the updated terminology of polyendocrine metabolic ovarian syndrome (PMOS).

Expert review of molecular diagnostics·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

Pharmacogenetics: an opportunity for codevelopment of pharmaceuticals and diagnostics

Related Concept Videos

Correlates of group sex participation among cisgender men who have sex with men in Seattle, WA.

Community-engaged research in HIV implementation science: a cross-sectional assessment of meaningful engagement among community and academic recipients of 2021 and 2022 'ending the HIV epidemic' supplement awards.

Challenges and Facilitators for HIV Testing Services and HIV Self-Testing Programming During Emergency Care in Kenya: A Qualitative Study of Patients.

Changes in sexual behaviors, network attributes, and STI testing among 15-44-year-olds by marital/cohabiting status and partner number: National Survey of Family Growth, 2008-19.

Community-engaged research in HIV implementation science: A cross-sectional assessment of meaningful engagement among community and academic recipients of 2021 and 2022 'ending the HIV epidemic' supplement awards.

Improving HIV assisted partner services outcomes by eliciting additional partners after the initial encounter.

The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.

Theranostic innovation in infectious lung diseases: integrating biotechnology and nanotechnology for precision medicine.

The expanding role of artificial intelligence in medical diagnosis: from molecular diagnostics and multi-omics to digital health and medical imaging.

Protein signatures for the early detection of endometrial cancer in cervico-vaginal fluid.

The association between normalized creatinine-to-cystatin C ratio and incident circadian syndrome in middle-aged and older adults: a national cohort study.

What's in a name: the potential impact of the updated terminology of polyendocrine metabolic ovarian syndrome (PMOS).

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

Pharmacogenetics: an opportunity for codevelopment of pharmaceuticals and diagnostics

Related Concept Videos

Related Articles